
Chou Associates Management
13F Holdings and Portfolio Analysis
Francis Chou 2016 Q1 13F holdings, quarterly changes, portfolio value trend and position weight distribution.
Chou Associates Management Overview
Chou Associates Management held 25 stocks in 2016 Q1, with total market value around $0.31B.
Chou Associates Management's top five holdings in 2016 Q1: ASCENT CAPITAL GROUP INC CV SR UNSEC NT 12.92%, BERKSHIRE HATHAWAY INC CL A(BRK.A) 10.41%, RESOLUTE FST PRODS INC 8.78%, VALEANT PHARMACEUTICALS INT INC 8.35%, NOKIA OYJ COMMON STOCK(NOK) 7.20%.
- Portfolio Value
- $0.31B
- Current Holdings
- 25 stocks
- New / Increased
- 1 / 2
- Reduced / Exited
- 1 / 0
Current Holdings
| 1 | ASCENT CAPITAL GROUP INC CV SR UNSEC NTCUSIP 043632AA6可转换债券 | 0.04 | 12.92% | 2.68 - | $14.83 | - | $1.01 | 0.00 | 1.75 | +$0.04B+1361.20% | Held |
| 2 | BERKSHIRE HATHAWAY INC CL ABRK.A | 0.03 | 10.41% | 0.00 -50.00% | $213733.33 | $705400.23 +230.04% | $168600.00 | -0.00 | 3.00 | +$0.08B+318.39% | Reduced |
| 3 | RESOLUTE FST PRODS INCCUSIP 76117W109 | 0.03 | 8.78% | 4.90 +4.25% | $5.52 | - | $12.24 | +0.20 | 3.00 | -$0.03B-54.91% | Increased |
| 4 | VALEANT PHARMACEUTICALS INT INCCUSIP 91911K102 | 0.03 | 8.35% | 0.98 | $26.33 | - | $26.33 | +0.98 | 0.25 | $0.00B0.00% | New |
| 5 | NOKIA OYJ COMMON STOCKNOK | 0.02 | 7.20% | 3.75 - | $5.92 | - | $3.74 | 0.00 | 3.00 | +$0.01B+58.23% | Held |
| 6 | ASCENT CAP GROUP INCCUSIP 43632108 | 0.02 | 6.87% | 0.34 - | $62.27 | - | $26.65 | 0.00 | 0.75 | +$0.01B+133.62% | Held |
| 7 | JPMORGAN CHASE & COCUSIP 46634E114 | 0.02 | 6.48% | 1.13 - | $17.72 | - | $20.81 | 0.00 | 1.50 | -$0.00B-14.82% | Held |
| 8 | Citigroup Inc.C | 0.02 | 5.56% | 0.41 - | $41.80 | $97.52 +133.27% | $47.97 | 0.00 | 3.00 | +$0.02B+103.29% | Held |
| 9 | SanofiSNY | 0.02 | 5.35% | 0.41 - | $40.21 | $49.22 +22.39% | $51.51 | 0.00 | 3.00 | -$0.00B-4.45% | Held |
| 10 | SEARS HLDGS CORPCUSIP 812350106 | 0.02 | 5.13% | 1.03 +15.12% | $15.33 | - | $39.79 | +0.14 | 3.00 | -$0.03B-61.47% | Increased |
| 11 | WELLS FARGO & CO NEWCUSIP 949746119 | 0.02 | 5.08% | 1.00 - | $15.68 | - | $13.67 | 0.00 | 3.00 | +$0.00B+14.71% | Held |
| 12 | The Goldman Sachs Group, Inc.GS | 0.01 | 3.83% | 0.07 - | $157.19 | $751.53 +378.11% | $151.25 | 0.00 | 3.00 | +$0.05B+396.87% | Held |
| 13 | MBIA INC COMMBI | 0.01 | 3.11% | 1.08 - | $8.86 | - | $13.31 | 0.00 | 3.00 | -$0.00B-33.42% | Held |
| 14 | SEARS HOMETOWN & OUTLET STORCUSIP 812362101 | 0.01 | 2.76% | 1.32 - | $6.43 | - | $11.59 | 0.00 | 1.75 | -$0.01B-44.54% | Held |
| 15 | OVERSTOCK COM INC DELCUSIP 690370101 | 0.01 | 2.72% | 0.58 - | $14.40 | - | $28.20 | 0.00 | 3.00 | -$0.01B-48.94% | Held |
| 16 | BLACKBERRY LTD COMBB | 0.00 | 1.40% | 0.53 - | $8.13 | - | $7.89 | 0.00 | 2.75 | +$0.00B+2.95% | Held |
| 17 | BANK OF AMERICA CORPORATIONCUSIP 060505146 | 0.00 | 1.06% | 0.84 - | $3.90 | - | $5.46 | 0.00 | 3.00 | -$0.00B-28.65% | Held |
| 18 | CHICAGO BRIDGE & IRON CO N CCUSIP 16725109 | 0.00 | 0.80% | 0.07 - | $36.64 | - | $39.68 | 0.00 | 0.75 | -$0.00B-7.66% | Held |
| 19 | SEARS CDA INCCUSIP 81234D109 | 0.00 | 0.71% | 0.78 - | $2.80 | - | $9.64 | 0.00 | 1.50 | -$0.01B-70.93% | Held |
| 20 | RYANAIR HOLDINGS PLC SPONSORED ADSRYAAY | 0.00 | 0.46% | 0.02 - | $85.91 | - | $86.46 | 0.00 | 0.50 | -$0.00B-0.63% | Held |
| 21 | POSCO HOLDINGS INC -SPON ADRPKX | 0.00 | 0.32% | 0.02 - | $47.38 | - | $35.05 | 0.00 | 0.75 | +$0.00B+35.19% | Held |
| 22 | AstraZeneca PLCAZN | 0.00 | 0.24% | 0.01 - | $56.15 | $84.69 +50.82% | $58.92 | 0.00 | 2.50 | +$0.00B+43.73% | Held |
| 23 | China Yuchai International LimitedCYD | 0.00 | 0.24% | 0.07 - | $9.87 | $34.95 +254.15% | $5.87 | 0.00 | 3.00 | +$0.00B+495.02% | Held |
| 24 | GSK plcGSK | 0.00 | 0.12% | 0.02 - | $20.33 | $44.09 +116.86% | $26.56 | 0.00 | 2.50 | +$0.00B+66.04% | Held |
| 25 | BP PLC-SPONS ADRBP | 0.00 | 0.10% | 0.01 - | $30.20 | - | $41.70 | 0.00 | 3.00 | -$0.00B-27.58% | Held |
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.
Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.
Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.
Portfolio Visuals
Track portfolio value, position weights and Top 10 history.